Molecular heterogeneity of non‐small cell lung carcinoma patient‐derived xenografts closely reflect their primary tumors

Availability of lung cancer models that closely mimic human tumors remains a significant gap in cancer research, as tumor cell lines and mouse models may not recapitulate the spectrum of lung cancer heterogeneity seen in patients. We aimed to establish a patient‐derived tumor xenograft (PDX) resourc...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of cancer Vol. 140; no. 3; pp. 662 - 673
Main Authors Wang, Dennis, Pham, Nhu‐An, Tong, Jiefei, Sakashita, Shingo, Allo, Ghassan, Kim, Lucia, Yanagawa, Naoki, Raghavan, Vibha, Wei, Yuhong, To, Christine, Trinh, Quang M., Starmans, Maud H.W., Chan‐Seng‐Yue, Michelle A., Chadwick, Dianne, Li, Lei, Zhu, Chang‐Qi, Liu, Ni, Li, Ming, Lee, Sharon, Ignatchenko, Vladimir, Strumpf, Dan, Taylor, Paul, Moghal, Nadeem, Liu, Geoffrey, Boutros, Paul C., Kislinger, Thomas, Pintilie, Melania, Jurisica, Igor, Shepherd, Frances A., McPherson, John D., Muthuswamy, Lakshmi, Moran, Michael F., Tsao, Ming‐Sound
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.02.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Availability of lung cancer models that closely mimic human tumors remains a significant gap in cancer research, as tumor cell lines and mouse models may not recapitulate the spectrum of lung cancer heterogeneity seen in patients. We aimed to establish a patient‐derived tumor xenograft (PDX) resource from surgically resected non‐small cell lung cancer (NSCLC). Fresh tumor tissue from surgical resection was implanted and grown in the subcutaneous pocket of non‐obese severe combined immune deficient (NOD SCID) gamma mice. Subsequent passages were in NOD SCID mice. A subset of matched patient and PDX tumors and non‐neoplastic lung tissues were profiled by whole exome sequencing, single nucleotide polymorphism (SNP) and methylation arrays, and phosphotyrosine (pY)‐proteome by mass spectrometry. The data were compared to published NSCLC datasets of NSCLC primary and cell lines. 127 stable PDXs were established from 441 lung carcinomas representing all major histological subtypes: 52 adenocarcinomas, 62 squamous cell carcinomas, one adeno‐squamous carcinoma, five sarcomatoid carcinomas, five large cell neuroendocrine carcinomas, and two small cell lung cancers. Somatic mutations, gene copy number and expression profiles, and pY‐proteome landscape of 36 PDXs showed greater similarity with patient tumors than with established cell lines. Novel somatic mutations on cancer associated genes were identified but only in PDXs, likely due to selective clonal growth in the PDXs that allows detection of these low allelic frequency mutations. The results provide the strongest evidence yet that PDXs established from lung cancers closely mimic the characteristics of patient primary tumors. What's new? Non‐small cell lung cancers (NSCLCs) are histologically and genetically diverse, with only a small fraction of patients exhibiting common cancer‐driving mutations. While translating that diversity into clinically relevant models has proven difficult, the present study suggests that at least some long‐standing challenges may be overcome with patient‐derived tumor xenografts (PDXs). PDXs were established by implanting and growing surgically resected human tumor tissue into mice. Subsequent genomic and proteomic profiling revealed fidelity between PDXs and the molecular pathology of matched patient tissues for a subset of models. Compared with cell lines, PDXs more completely recapitulated lung cancer pathogenesis in patients.
AbstractList Availability of lung cancer models that closely mimic human tumors remains a significant gap in cancer research, as tumor cell lines and mouse models may not recapitulate the spectrum of lung cancer heterogeneity seen in patients. We aimed to establish a patient-derived tumor xenograft (PDX) resource from surgically resected non-small cell lung cancer (NSCLC). Fresh tumor tissue from surgical resection was implanted and grown in the subcutaneous pocket of non-obese severe combined immune deficient (NOD SCID) gamma mice. Subsequent passages were in NOD SCID mice. A subset of matched patient and PDX tumors and non-neoplastic lung tissues were profiled by whole exome sequencing, single nucleotide polymorphism (SNP) and methylation arrays, and phosphotyrosine (pY)-proteome by mass spectrometry. The data were compared to published NSCLC datasets of NSCLC primary and cell lines. 127 stable PDXs were established from 441 lung carcinomas representing all major histological subtypes: 52 adenocarcinomas, 62 squamous cell carcinomas, one adeno-squamous carcinoma, five sarcomatoid carcinomas, five large cell neuroendocrine carcinomas, and two small cell lung cancers. Somatic mutations, gene copy number and expression profiles, and pY-proteome landscape of 36 PDXs showed greater similarity with patient tumors than with established cell lines. Novel somatic mutations on cancer associated genes were identified but only in PDXs, likely due to selective clonal growth in the PDXs that allows detection of these low allelic frequency mutations. The results provide the strongest evidence yet that PDXs established from lung cancers closely mimic the characteristics of patient primary tumors. What's new? Non-small cell lung cancers (NSCLCs) are histologically and genetically diverse, with only a small fraction of patients exhibiting common cancer-driving mutations. While translating that diversity into clinically relevant models has proven difficult, the present study suggests that at least some long-standing challenges may be overcome with patient-derived tumor xenografts (PDXs). PDXs were established by implanting and growing surgically resected human tumor tissue into mice. Subsequent genomic and proteomic profiling revealed fidelity between PDXs and the molecular pathology of matched patient tissues for a subset of models. Compared with cell lines, PDXs more completely recapitulated lung cancer pathogenesis in patients.
Availability of lung cancer models that closely mimic human tumors remains a significant gap in cancer research, as tumor cell lines and mouse models may not recapitulate the spectrum of lung cancer heterogeneity seen in patients. We aimed to establish a patient‐derived tumor xenograft (PDX) resource from surgically resected non‐small cell lung cancer (NSCLC). Fresh tumor tissue from surgical resection was implanted and grown in the subcutaneous pocket of non‐obese severe combined immune deficient (NOD SCID) gamma mice. Subsequent passages were in NOD SCID mice. A subset of matched patient and PDX tumors and non‐neoplastic lung tissues were profiled by whole exome sequencing, single nucleotide polymorphism (SNP) and methylation arrays, and phosphotyrosine (pY)‐proteome by mass spectrometry. The data were compared to published NSCLC datasets of NSCLC primary and cell lines. 127 stable PDXs were established from 441 lung carcinomas representing all major histological subtypes: 52 adenocarcinomas, 62 squamous cell carcinomas, one adeno‐squamous carcinoma, five sarcomatoid carcinomas, five large cell neuroendocrine carcinomas, and two small cell lung cancers. Somatic mutations, gene copy number and expression profiles, and pY‐proteome landscape of 36 PDXs showed greater similarity with patient tumors than with established cell lines. Novel somatic mutations on cancer associated genes were identified but only in PDXs, likely due to selective clonal growth in the PDXs that allows detection of these low allelic frequency mutations. The results provide the strongest evidence yet that PDXs established from lung cancers closely mimic the characteristics of patient primary tumors. What's new? Non‐small cell lung cancers (NSCLCs) are histologically and genetically diverse, with only a small fraction of patients exhibiting common cancer‐driving mutations. While translating that diversity into clinically relevant models has proven difficult, the present study suggests that at least some long‐standing challenges may be overcome with patient‐derived tumor xenografts (PDXs). PDXs were established by implanting and growing surgically resected human tumor tissue into mice. Subsequent genomic and proteomic profiling revealed fidelity between PDXs and the molecular pathology of matched patient tissues for a subset of models. Compared with cell lines, PDXs more completely recapitulated lung cancer pathogenesis in patients.
Availability of lung cancer models that closely mimic human tumors remains a significant gap in cancer research, as tumor cell lines and mouse models may not recapitulate the spectrum of lung cancer heterogeneity seen in patients. We aimed to establish a patient-derived tumor xenograft (PDX) resource from surgically resected non-small cell lung cancer (NSCLC). Fresh tumor tissue from surgical resection was implanted and grown in the subcutaneous pocket of non-obese severe combined immune deficient (NOD SCID) gamma mice. Subsequent passages were in NOD SCID mice. A subset of matched patient and PDX tumors and non-neoplastic lung tissues were profiled by whole exome sequencing, single nucleotide polymorphism (SNP) and methylation arrays, and phosphotyrosine (pY)-proteome by mass spectrometry. The data were compared to published NSCLC datasets of NSCLC primary and cell lines. 127 stable PDXs were established from 441 lung carcinomas representing all major histological subtypes: 52 adenocarcinomas, 62 squamous cell carcinomas, one adeno-squamous carcinoma, five sarcomatoid carcinomas, five large cell neuroendocrine carcinomas, and two small cell lung cancers. Somatic mutations, gene copy number and expression profiles, and pY-proteome landscape of 36 PDXs showed greater similarity with patient tumors than with established cell lines. Novel somatic mutations on cancer associated genes were identified but only in PDXs, likely due to selective clonal growth in the PDXs that allows detection of these low allelic frequency mutations. The results provide the strongest evidence yet that PDXs established from lung cancers closely mimic the characteristics of patient primary tumors.
Author McPherson, John D.
Li, Ming
Pham, Nhu‐An
Boutros, Paul C.
Lee, Sharon
Wang, Dennis
Yanagawa, Naoki
Moghal, Nadeem
Liu, Ni
Tsao, Ming‐Sound
Ignatchenko, Vladimir
To, Christine
Chan‐Seng‐Yue, Michelle A.
Allo, Ghassan
Starmans, Maud H.W.
Muthuswamy, Lakshmi
Raghavan, Vibha
Trinh, Quang M.
Strumpf, Dan
Kim, Lucia
Jurisica, Igor
Wei, Yuhong
Shepherd, Frances A.
Zhu, Chang‐Qi
Tong, Jiefei
Pintilie, Melania
Taylor, Paul
Kislinger, Thomas
Liu, Geoffrey
Sakashita, Shingo
Chadwick, Dianne
Li, Lei
Moran, Michael F.
Author_xml – sequence: 1
  givenname: Dennis
  surname: Wang
  fullname: Wang, Dennis
  organization: Sheffield Institute of Translational Neuroscience, University of Sheffield
– sequence: 2
  givenname: Nhu‐An
  surname: Pham
  fullname: Pham, Nhu‐An
  organization: Princess Margaret Cancer Centre, University Health Network
– sequence: 3
  givenname: Jiefei
  surname: Tong
  fullname: Tong, Jiefei
  organization: Hospital for Sick Children
– sequence: 4
  givenname: Shingo
  surname: Sakashita
  fullname: Sakashita, Shingo
  organization: University of Toronto
– sequence: 5
  givenname: Ghassan
  surname: Allo
  fullname: Allo, Ghassan
  organization: University of Toronto
– sequence: 6
  givenname: Lucia
  surname: Kim
  fullname: Kim, Lucia
  organization: University of Toronto
– sequence: 7
  givenname: Naoki
  surname: Yanagawa
  fullname: Yanagawa, Naoki
  organization: University of Toronto
– sequence: 8
  givenname: Vibha
  surname: Raghavan
  fullname: Raghavan, Vibha
  organization: Princess Margaret Cancer Centre, University Health Network
– sequence: 9
  givenname: Yuhong
  surname: Wei
  fullname: Wei, Yuhong
  organization: Hospital for Sick Children
– sequence: 10
  givenname: Christine
  surname: To
  fullname: To, Christine
  organization: Princess Margaret Cancer Centre, University Health Network
– sequence: 11
  givenname: Quang M.
  surname: Trinh
  fullname: Trinh, Quang M.
  organization: Ontario Institute of Cancer Research
– sequence: 12
  givenname: Maud H.W.
  surname: Starmans
  fullname: Starmans, Maud H.W.
  organization: Ontario Institute of Cancer Research
– sequence: 13
  givenname: Michelle A.
  surname: Chan‐Seng‐Yue
  fullname: Chan‐Seng‐Yue, Michelle A.
  organization: Ontario Institute of Cancer Research
– sequence: 14
  givenname: Dianne
  surname: Chadwick
  fullname: Chadwick, Dianne
  organization: Princess Margaret Cancer Centre, University Health Network
– sequence: 15
  givenname: Lei
  surname: Li
  fullname: Li, Lei
  organization: Hospital for Sick Children
– sequence: 16
  givenname: Chang‐Qi
  surname: Zhu
  fullname: Zhu, Chang‐Qi
  organization: Princess Margaret Cancer Centre, University Health Network
– sequence: 17
  givenname: Ni
  surname: Liu
  fullname: Liu, Ni
  organization: Princess Margaret Cancer Centre, University Health Network
– sequence: 18
  givenname: Ming
  surname: Li
  fullname: Li, Ming
  organization: Princess Margaret Cancer Centre, University Health Network
– sequence: 19
  givenname: Sharon
  surname: Lee
  fullname: Lee, Sharon
  organization: Princess Margaret Cancer Centre, University Health Network
– sequence: 20
  givenname: Vladimir
  surname: Ignatchenko
  fullname: Ignatchenko, Vladimir
  organization: Princess Margaret Cancer Centre, University Health Network
– sequence: 21
  givenname: Dan
  surname: Strumpf
  fullname: Strumpf, Dan
  organization: Princess Margaret Cancer Centre, University Health Network
– sequence: 22
  givenname: Paul
  surname: Taylor
  fullname: Taylor, Paul
  organization: Hospital for Sick Children
– sequence: 23
  givenname: Nadeem
  surname: Moghal
  fullname: Moghal, Nadeem
  organization: University of Toronto
– sequence: 24
  givenname: Geoffrey
  surname: Liu
  fullname: Liu, Geoffrey
  organization: University of Toronto
– sequence: 25
  givenname: Paul C.
  surname: Boutros
  fullname: Boutros, Paul C.
  organization: University of Toronto
– sequence: 26
  givenname: Thomas
  surname: Kislinger
  fullname: Kislinger, Thomas
  organization: University of Toronto
– sequence: 27
  givenname: Melania
  surname: Pintilie
  fullname: Pintilie, Melania
  organization: Princess Margaret Cancer Centre, University Health Network
– sequence: 28
  givenname: Igor
  surname: Jurisica
  fullname: Jurisica, Igor
  organization: University of Toronto
– sequence: 29
  givenname: Frances A.
  surname: Shepherd
  fullname: Shepherd, Frances A.
  organization: University of Toronto
– sequence: 30
  givenname: John D.
  surname: McPherson
  fullname: McPherson, John D.
  organization: University of Toronto
– sequence: 31
  givenname: Lakshmi
  surname: Muthuswamy
  fullname: Muthuswamy, Lakshmi
  organization: University of Toronto
– sequence: 32
  givenname: Michael F.
  surname: Moran
  fullname: Moran, Michael F.
  organization: Molecular Genetics, University of Toronto
– sequence: 33
  givenname: Ming‐Sound
  surname: Tsao
  fullname: Tsao, Ming‐Sound
  email: ming.tsao@uhn.on.ca
  organization: University of Toronto
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27750381$$D View this record in MEDLINE/PubMed
BookMark eNpdkc9O3DAQxi20FbtLe-AFkKVeuATsOImdI1qVdhGoFzhHjjNZvHLsxXYoK3HoI_CMPEm9sHDoZWak76f5983RxDoLCB1TckYJyc_1Wp0xUvD8AM0oqXlGclpO0CxpJOOUVVM0D2FNCKUlKQ7RNOe8JEzQGXq-cQbUaKTH9xDBuxVY0HGLXY_TlNe_L2GQxmAFKZjRrrCSXmnrBok3MmqwMTEdeP0IHX4C61Ze9jFgZVwAs8Ue-jQg4ngP2uON14P0WxzHwfnwFX3ppQnwbZ-P0N3lj9vFr-z698_l4uI6U0zwPKsEkLaTVSsK0YmOq1IxXpdFyxmXfRJ4W0LOcsWLjtVdX8u6gly1SpG2hV6wI3T63nfj3cMIITaDDruLpAU3hoaKsiScV5Qk9Pt_6NqN3qbtElWIohKs2jU82VNjO0DX7M9qPv6agPN34I82sP3UKWl2hjXJsObNsGZ5tXgr2D-pYo58
CitedBy_id crossref_primary_10_1155_2022_3135470
crossref_primary_10_1158_1078_0432_CCR_19_1376
crossref_primary_10_1158_1078_0432_CCR_18_0717
crossref_primary_10_1186_s12967_020_02473_y
crossref_primary_10_1016_j_tranon_2021_101179
crossref_primary_10_1016_j_ejca_2020_10_036
crossref_primary_10_3390_cancers15112961
crossref_primary_10_1186_s12967_022_03405_8
crossref_primary_10_51335_organoid_2021_1_e6
crossref_primary_10_3390_ph16071042
crossref_primary_10_1186_s12935_022_02454_9
crossref_primary_10_3390_cancers11071009
crossref_primary_10_1111_cas_14081
crossref_primary_10_1016_j_jtho_2021_09_008
crossref_primary_10_1016_j_ymthe_2023_05_007
crossref_primary_10_3389_fonc_2022_961266
crossref_primary_10_3389_fonc_2021_648097
crossref_primary_10_3390_cancers15204996
crossref_primary_10_1007_s12094_024_03450_3
crossref_primary_10_1186_s12935_023_02953_3
crossref_primary_10_1158_0008_5472_CAN_19_0349
crossref_primary_10_1007_s11626_017_0207_5
crossref_primary_10_1074_mcp_M116_064451
crossref_primary_10_1016_j_lungcan_2024_107863
crossref_primary_10_1016_j_xcrm_2022_100911
crossref_primary_10_1002_cncr_32366
crossref_primary_10_3390_cancers11101488
crossref_primary_10_3390_cells8080889
crossref_primary_10_1016_j_tranon_2018_09_008
crossref_primary_10_3390_biomedicines10071677
crossref_primary_10_1177_11769351221136056
crossref_primary_10_1111_bph_16141
crossref_primary_10_1158_1535_7163_MCT_17_0174
crossref_primary_10_1002_cam4_5311
crossref_primary_10_1038_s41416_020_0933_4
crossref_primary_10_3390_ijms21114118
crossref_primary_10_1186_s40425_019_0507_2
crossref_primary_10_1158_1078_0432_CCR_17_1098
crossref_primary_10_1186_s12951_024_02627_w
crossref_primary_10_3389_fonc_2023_1260411
crossref_primary_10_1186_s13073_018_0562_1
crossref_primary_10_1080_17460441_2018_1437137
crossref_primary_10_1186_s12964_023_01332_9
crossref_primary_10_3390_ijms22062907
crossref_primary_10_1098_rsob_200247
crossref_primary_10_3390_ijms25031486
crossref_primary_10_1016_j_biopha_2017_12_081
crossref_primary_10_1016_j_bspc_2022_103643
crossref_primary_10_1038_s41467_022_29444_9
crossref_primary_10_1038_s41598_017_06544_x
crossref_primary_10_1186_s12890_023_02809_6
crossref_primary_10_3892_ol_2018_7890
crossref_primary_10_1002_ijc_32662
crossref_primary_10_3389_fonc_2023_1156743
ContentType Journal Article
Copyright 2016 UICC
2016 UICC.
2017 UICC
Copyright_xml – notice: 2016 UICC
– notice: 2016 UICC.
– notice: 2017 UICC
DBID CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TO
7U9
H94
K9.
DOI 10.1002/ijc.30472
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
DatabaseTitleList AIDS and Cancer Research Abstracts
Oncogenes and Growth Factors Abstracts

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-0215
EndPage 673
ExternalDocumentID 4277437321
27750381
IJC30472
Genre article
Journal Article
GrantInformation_xml – fundername: Ontario Premier's Summit Award (to F.A.S.)
– fundername: Canadian Cancer Society
  funderid: #020527 (to M.S.T.) and #701595 (to M.S.T.)
– fundername: Ontario Research Fund‐Research Excellence
  funderid: RE‐03–020
– fundername: Princess Margaret Hospital Cancer Foundation Investment in Research Program (to B.W.), Ontario Institute of Cancer Research (OICR) (to P.C.B. and J.D.M.), Ontario Ministry of Health and Long Term Care, and Canada Research Chairs Program (to T.K., M.F.M., I.J.)
– fundername: Canadian Institutes for Health Research (CIHR); Grant number:
  funderid: MOP‐102536 (to M.M.)
GroupedDBID ---
-~X
.3N
.GA
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
EMOBN
F00
F01
F04
F5P
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HGLYW
HHY
HHZ
HZ~
IH2
IX1
J0M
JPC
KBYEO
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
ROL
RWI
RX1
RYL
SUPJJ
TEORI
UB1
UDS
V2E
V8K
V9Y
W2D
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WWO
WXI
WXSBR
XG1
XPP
XV2
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TO
7U9
AAMNL
H94
K9.
ID FETCH-LOGICAL-c3872-68e0bda6b848d8d7c5c37954b737afda67b5e232c74d39df9a96e2cbcc0bbef83
IEDL.DBID DR2
ISSN 0020-7136
IngestDate Wed Dec 04 09:42:21 EST 2024
Sun Nov 24 17:26:20 EST 2024
Sat Sep 28 07:59:18 EDT 2024
Sat Aug 24 00:51:01 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords non-small cell lung cancer
xenograft
transcriptome
DNA methylation
mass spectrometry
phosphotyrosine-proteomics
copy number aberration
whole exome next generation sequencing
Language English
License 2016 UICC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3872-68e0bda6b848d8d7c5c37954b737afda67b5e232c74d39df9a96e2cbcc0bbef83
Notes Administrative, material support (i.e., provision of tumor tissue)
D. Wang, N.‐A. Pham, J. Tong, S. Sakashita, G. Allo, L. Kim, N. Yanagawa, V. Raghavan, Y. Wei, C. To, Q.M. Trinh, M. H.W. Starmans, M.A. Chan‐Seng‐Yue, L. Li, C.‐Q. Zhu, N. Liu, M. Li, S. Lee, V. Ignatchenko, D. Strumpf, P. Taylor, N. Moghal, G. Liu, P.C. Boutros, T. Kislinger, M. Pintilie, I. Jurisica, J.D. McPherson, L. Muthuswamy, M.F. Moran, M.‐S. Tsao
D. Wang, N.‐A. Pham, J. Tong, L. Li, C.‐Q. Zhu, N. Moghal, G. Liu, P.C. Boutros, T. Kislinger, M. Pintilie, I. Jurisica, F.A. Shepherd, J.D. McPherson, M.F. Moran, M.‐S. Tsao
N.‐A. Pham, D. Chadwick, M. Li, G. Liu, F.A. Shepherd, M.‐S. Tsao
Data collection
D. Wang, N.‐A. Pham, J. Tong, S. Sakashita, G. Allo, L. Kim, N. Yanagawa, Y. Wei, C. To, Q.M. Trinh, M. H.W. Starmans, D. Chadwick, L. Li, C.‐Q. Zhu, N. Liu, M. Li, S. Lee, V. Ignatchenko, D. Strumpf, P. Taylor, P.C. Boutros, M. Pintilie, J.D. McPherson, L. Muthuswamy, M.F. Moran, M.‐S. Tsao
D. Wang, N. Moghal, G. Liu, T. Kislinger, I. Jurisica, F.A. Shepherd, J.D. McPherson, M.F. Moran, M.‐S. Tsao
Conception and design
Data analysis and interpretation
Writing, review of manuscript
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://eprints.whiterose.ac.uk/113009/7/Molecular%20heterogeneity%20of%20non-small%20cell%20lung%20carcinoma.pdf
PMID 27750381
PQID 1848468368
PQPubID 105430
PageCount 12
ParticipantIDs proquest_miscellaneous_1855077610
proquest_journals_1848468368
pubmed_primary_27750381
wiley_primary_10_1002_ijc_30472_IJC30472
PublicationCentury 2000
PublicationDate 1 February 2017
2017-Feb-01
20170201
PublicationDateYYYYMMDD 2017-02-01
PublicationDate_xml – month: 02
  year: 2017
  text: 1 February 2017
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle International journal of cancer
PublicationTitleAlternate Int J Cancer
PublicationYear 2017
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2010; 10
2009; 69
2012; 483
2013; 4
2015; 16
2015; 4
2010; 107
2013; 105
2010; 203
2015; 33
2008; 14
2013; 93
2011; 10
2011; 17
2012; 489
2014; 232
2012; 12
2012; 11
2001; 84
2014; 511
2014; 134
2012; 72
2012; 150
2014; 5
2010; 68
2015; 357
2010; 28
2013; 73
2013; 31
2015; 21
2007; 131
2015; 43
2008; 26
2014; 14
2015; 518
2014; 35
2014; 13
1985; 51
2012; 28
2013; 110
2013
2014; 93
2014; 344
2012; 9
References_xml – volume: 110
  start-page: 4245
  year: 2013
  end-page: 50
  article-title: Pattern discovery and cancer gene identification in integrated cancer genomic data
  publication-title: Proc Natl Acad Sci U S A
– volume: 28
  start-page: 1811
  year: 2012
  end-page: 7
  article-title: Strelka: accurate somatic small‐variant calling from sequenced tumor‐normal sample pairs
  publication-title: Bioinformatics
– volume: 10
  start-page: 241
  year: 2010
  end-page: 53
  article-title: Cell line‐based platforms to evaluate the therapeutic efficacy of candidate anticancer agents
  publication-title: Nat Rev Cancer
– volume: 21
  start-page: 1318
  year: 2015
  end-page: 25
  article-title: High‐throughput screening using patient‐derived tumor xenografts to predict clinical trial drug response
  publication-title: Nat Med
– volume: 28
  start-page: i172
  year: 2012
  end-page: 8
  article-title: Xenome–a tool for classifying reads from xenograft samples
  publication-title: Bioinformatics
– volume: 489
  start-page: 519
  year: 2012
  end-page: 25
  article-title: Comprehensive genomic characterization of squamous cell lung cancers
  publication-title: Nature
– volume: 93
  start-page: 970
  year: 2013
  end-page: 82
  article-title: Patient‐derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century
  publication-title: Lab Invest
– volume: 4
  start-page: 2126
  year: 2013
  article-title: Evaluating cell lines as tumour models by comparison of genomic profiles
  publication-title: Nat Commun
– volume: 483
  start-page: 603
  year: 2012
  end-page: 7
  article-title: The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity
  publication-title: Nature
– volume: 4
  start-page: 201
  year: 2015
  end-page: 11
  article-title: Setting up a wide panel of patient‐derived tumor xenografts of non‐small cell lung cancer by improving the preanalytical steps
  publication-title: Cancer Med
– volume: 10
  start-page: 1794
  year: 2011
  end-page: 805
  article-title: Andromeda: a peptide search engine integrated into the MaxQuant environment
  publication-title: J Proteome Res
– volume: 16
  start-page: 165
  year: 2015
  end-page: 72
  article-title: Bridging tumor genomics to patient outcomes through an integrated patient‐derived xenograft platform
  publication-title: Clin Lung Cancer
– volume: 4
  start-page: 2617
  year: 2013
  article-title: Reconstructing targetable pathways in lung cancer by integrating diverse omics data
  publication-title: Nat Commun
– volume: 28
  start-page: 4417
  year: 2010
  end-page: 24
  article-title: Prognostic and predictive gene signature for adjuvant chemotherapy in resected non‐small‐cell lung cancer
  publication-title: J Clin Oncol
– volume: 203
  start-page: 7
  year: 2010
  end-page: 15
  article-title: Somatic mutations of signaling genes in non‐small‐cell lung cancer
  publication-title: Cancer Genet Cytogenet
– volume: 17
  start-page: 134
  year: 2011
  end-page: 41
  article-title: The ability to form primary tumor xenografts is predictive of increased risk of disease recurrence in early‐stage non‐small cell lung cancer
  publication-title: Clin Cancer Res
– volume: 73
  start-page: 4885
  year: 2013
  end-page: 97
  article-title: A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient‐derived human breast cancer xenograft models
  publication-title: Cancer Res
– volume: 357
  start-page: 179
  year: 2015
  end-page: 85
  article-title: Gene mutations in primary tumors and corresponding patient‐derived xenografts derived from non‐small cell lung cancer
  publication-title: Cancer Lett
– volume: 12
  start-page: 252
  year: 2012
  end-page: 64
  article-title: The blockade of immune checkpoints in cancer immunotherapy
  publication-title: Nat Rev Cancer
– volume: 107
  start-page: 16910
  year: 2010
  end-page: 5
  article-title: Allele‐specific copy number analysis of tumors
  publication-title: Proc Natl Acad Sci U S A
– volume: 9
  start-page: 215
  year: 2012
  end-page: 24
  article-title: Engineering humanized mice for improved hematopoietic reconstitution
  publication-title: Cell Mol Immunol
– volume: 344
  start-page: 1
  year: 2014
  end-page: 12
  article-title: One mouse, one patient paradigm: new avatars of personalized cancer therapy
  publication-title: Cancer Lett
– volume: 68
  start-page: 309
  year: 2010
  end-page: 18
  article-title: Lung cancer cell lines: useless artifacts or invaluable tools for medical science?
  publication-title: Lung Cancer
– volume: 35
  start-page: 1671
  year: 2014
  end-page: 9
  article-title: Three‐dimensional cancer models mimic cell‐matrix interactions in the tumour microenvironment
  publication-title: Carcinogenesis
– volume: 69
  start-page: 3364
  year: 2009
  end-page: 73
  article-title: A primary xenograft model of small‐cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro
  publication-title: Cancer Res
– volume: 84
  start-page: 1424
  year: 2001
  end-page: 31
  article-title: Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials
  publication-title: Br J Cancer
– volume: 31
  start-page: 298
  year: 2013
  end-page: 304
  article-title: Dissociation of c‐Met phosphotyrosine sites in human cells in response to mouse hepatocyte growth factor but not human hepatocyte growth factor: the possible roles of different amino acids in different species
  publication-title: Cell Biochem Funct
– volume: 11
  start-page: 77
  year: 2012
  end-page: 89
  article-title: Super‐SILAC allows classification of diffuse large B‐cell lymphoma subtypes by their protein expression profiles
  publication-title: Mol Cell Proteomics: MCP
– volume: 5
  start-page: 5469
  year: 2014
  article-title: Integrated omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact
  publication-title: Nat Commun
– volume: 14
  start-page: 535
  year: 2014
  end-page: 46
  article-title: Non‐small‐cell lung cancers: a heterogeneous set of diseases
  publication-title: Nat Rev Cancer
– volume: 93
  start-page: e298
  year: 2014
  article-title: Genomic profiling of patient‐derived colon cancer xenograft models
  publication-title: Medicine
– volume: 14
  start-page: 6456
  year: 2008
  end-page: 68
  article-title: Establishment of patient‐derived non‐small cell lung cancer xenografts as models for the identification of predictive biomarkers
  publication-title: Clin Cancer Res
– volume: 105
  start-page: 452
  year: 2013
  end-page: 8
  article-title: The clinical relevance of cancer cell lines
  publication-title: J Natl Cancer Inst
– volume: 43
  start-page: D805
  year: 2015
  end-page: 11
  article-title: COSMIC: exploring the world's knowledge of somatic mutations in human cancer
  publication-title: Nucleic Acid Res
– volume: 51
  start-page: 195
  year: 1985
  end-page: 200
  article-title: Growth of human bronchial carcinomas in nude mice
  publication-title: Br J Cancer
– volume: 483
  start-page: 613
  year: 2012
  end-page: 7
  article-title: A murine lung cancer co‐clinical trial identifies genetic modifiers of therapeutic response
  publication-title: Nature
– volume: 33
  start-page: 2472
  year: 2015
  end-page: 80
  article-title: Clinical utility of patient‐derived xenografts to determine biomarkers of prognosis and map resistance pathways in EGFR‐mutant lung adenocarcinoma
  publication-title: J Clin Oncol
– volume: 26
  start-page: 1367
  year: 2008
  end-page: 72
  article-title: MaxQuant enables high peptide identification rates, individualized p.p.b.‐range mass accuracies and proteome‐wide protein quantification
  publication-title: Nat Biotechnol
– volume: 518
  start-page: 422
  year: 2015
  end-page: 426
  article-title: Population dynamics of genomic clones in breast cancer patient xenografts at single cell resolution
  publication-title: Nature
– volume: 13
  start-page: 1644
  year: 2014
  end-page: 58
  article-title: Proteomic analysis of the epidermal growth factor receptor (EGFR) interactome and post‐translational modifications associated with receptor endocytosis in response to EGF and stress
  publication-title: Mol Cell Proteom
– volume: 483
  start-page: 570
  year: 2012
  end-page: 5
  article-title: Systematic identification of genomic markers of drug sensitivity in cancer cells
  publication-title: Nature
– volume: 72
  start-page: 2695
  year: 2012
  end-page: 700
  article-title: Genetically engineered mouse models: closing the gap between preclinical data and trial outcomes
  publication-title: Cancer Res
– volume: 150
  start-page: 1107
  year: 2012
  end-page: 20
  article-title: Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing
  publication-title: Cell
– volume: 72
  start-page: 3048
  year: 2012
  end-page: 59
  article-title: MEK1/2 inhibition elicits regression of autochthonous lung tumors induced by KRASG12D or BRAFV600E
  publication-title: Cancer Res
– volume: 134
  start-page: 789
  year: 2014
  end-page: 98
  article-title: Gene expression profile of A549 cells from tissue of 4D model predicts poor prognosis in lung cancer patients
  publication-title: Int J Cancer
– volume: 232
  start-page: 449
  year: 2014
  end-page: 57
  article-title: Versatile and enhanced tumour modelling in mice via somatic cell transduction
  publication-title: J Pathol
– volume: 511
  start-page: 543
  year: 2014
  end-page: 50
  article-title: Comprehensive molecular profiling of lung adenocarcinoma
  publication-title: Nature
– volume: 131
  start-page: 1190
  year: 2007
  end-page: 203
  article-title: Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer
  publication-title: Cell
– year: 2013
– volume: 26
  start-page: 1346
  year: 2008
  end-page: 54
  article-title: Review of phase II trial designs used in studies of molecular targeted agents: outcomes and predictors of success in phase III
  publication-title: J Clin Oncol
SSID ssj0011504
Score 2.5095525
Snippet Availability of lung cancer models that closely mimic human tumors remains a significant gap in cancer research, as tumor cell lines and mouse models may not...
SourceID proquest
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 662
SubjectTerms Adult
Aged
Animals
Cancer
Carcinoma, Non-Small-Cell Lung - genetics
Carcinoma, Non-Small-Cell Lung - pathology
Cell Line, Tumor
copy number aberration
Disease Models, Animal
DNA methylation
Female
Heterografts - pathology
Humans
Lung cancer
Lung Neoplasms - genetics
Lung Neoplasms - pathology
Male
mass spectrometry
Medical research
Mice
Mice, Inbred NOD
Mice, SCID
Middle Aged
Mutation
Mutation - genetics
non‐small cell lung cancer
Patients
phosphotyrosine‐proteomics
Polymorphism, Single Nucleotide - genetics
Rodents
transcriptome
Tumors
whole exome next generation sequencing
xenograft
Xenograft Model Antitumor Assays - methods
Title Molecular heterogeneity of non‐small cell lung carcinoma patient‐derived xenografts closely reflect their primary tumors
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijc.30472
https://www.ncbi.nlm.nih.gov/pubmed/27750381
https://www.proquest.com/docview/1848468368
https://search.proquest.com/docview/1855077610
Volume 140
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hDqgXHi2PLVC5Ug9csuzGSeyIU0WLKNL2gEDigBTFL_HIJhXJIlpx4CfwG_tLmMmrAnFAvUXxRLIzD3_2jD8DfBE2dtz5xlNjG3iBUr6nEJd6WuBbIXhoHB1OnvyMDk-Do7PwbA72urMwDT9Ev-FGnlHHa3LwVJW7_0hDL6_0kHJGFH_HXFA537fjnjqKgE7LwDzycCEWdaxCI3-3__I1VPkcpNazzMESnHf9a4pLroezSg31nxfUjf85gGVYbNEn-9qYywrM2fw9LEza_PoHuJ90t-WyC6qTKdC8LOJ0VjiWF_nfh8dymmYZo-1-lmGcYJruIsqLacpahlaUMWjVt9awO5tT8ZerSqazorTZb4bzMeUJWJ2fYL8aqgtWzabFTbkKpwffT_YPvfZ-Bk9zKXwvknakTBopGUgjjdCh5iIOAyW4SB02CBVaRGxaBIbHxsVpHFlfK61HSlkn-RrMY9_tBrA4RBjBx6mxlLY1GFWINj5w0gnNlR8MYKvTVNI6WZng4hTRk-SRHMDnvhndg35CmttiRjJE2CYQJA5gvdFw0g4uQVskMpzxAHZqPfUNDZWzn6CGklpDyY-j_frh49tFN-GdTxCgrvDegvnqZma3EcBU6lNtqU81GPCk
link.rule.ids 314,780,784,1375,27924,27925,46294,46718
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9VAFD4hmAgbRB5yFXRIWLDp5d5O25kmbghCLshlYSBhQ5rOK6i9raG9Ro0Lf4K_0V_iOX0ZiQvirulMk5mex3xzzplvAPaEjR13vvHU2AZeoJTvKcSlnhb4VggeGkeHk6cX0eQqOLsOrxfgdXcWpuGH6ANuZBm1vyYDp4D0wR_W0Pcf9JCSRuiAH6G5j6mg6827njyKoE7LwTzycCsWdbxCI_-g__RfuPJvmFqvMydP4KYbYVNe8nE4r9RQf7tH3vi_U1iFlRaAssNGY57Cgs3X4PG0TbGvw_dpd2Euu6VSmQI1zCJUZ4VjeZH_-vGznKVZxijizzJ0FUzTdUR5MUtZS9KKfQwq9mdr2BebU_2Xq0qms6K02VeGSzKlClidomCfGrYLVs1nxV25AVcnx5dHE6-9osHTXArfi6QdKZNGSgbSSCN0qLmIw0AJLlKHDUKFFkGbFoHhsXFxGkfW10rrkVLWSb4Jizh2uwUsDhFJ8HFqLGVuDToWYo4PnHRCc-UHA9juRJW0dlYmuD9FACV5JAew2zejhdBPSHNbzKkPcbYJxIkDeNaIOGknl6A6Eh_OeAD7taD6hobN2U9QQkktoeT07Kh-eP7wrq9gaXI5PU_OTy_evoBlnxBBXfC9DYvV3dzuIJ6p1MtabX8DPYL0xQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRaq48H4sFDASBy7Z7tpO7IhT1bJqC1shRKUekKL4JR7ZpGqyCBCH_gR-I7-EmbwQiAPiFsUTyc48_Nkz_gzwRPk0iMBdZOZeRtIYHhnEpZFV-FYpEbtAh5OXx8nBiTw6jU834NlwFqbjhxg33Mgz2nhNDn7mws4v0tD3H-yUckYYfy_JhKdEnL__euSOIqTTUzDPIlyJJQOt0IzvjJ_-DVb-jlLbaWZxFd4OHeyqSz5O142Z2q9_cDf-5wiuwZUefrLdzl6uw4Yvb8DWsk-w34Rvy-G6XPaOCmUqtC-PQJ1VgZVV-ePie73Ki4LRfj8rMFAwS5cRldUqZz1FK8o4NOtP3rHPvqTqr9DUzBZV7YsvDCdkShSwNkHBzjquC9asV9V5fQtOFs_f7B1E_QUNkRVa8SjRfmZcnhgttdNO2dgKlcbSKKHygA3KxB4hm1XSidSFNE8Tz62xdmaMD1rchk3su78LLI0RR4h57jzlbR2GFeKNl0EHZYXhcgLbg6ay3svqDFenCJ-0SPQEHo_N6B_0E_LSV2uSIcY2hShxAnc6DWf94DI0RmLDmU_gaaunsaHjcuYZaihrNZQdHu21D_f-XfQRbL3aX2QvD49f3IfLnOBAW-29DZvN-do_QDDTmIet0f4EeijzdA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Molecular+heterogeneity+of+non-small+cell+lung+carcinoma+patient-derived+xenografts+closely+reflect+their+primary+tumors&rft.jtitle=International+journal+of+cancer&rft.au=Wang%2C+Dennis&rft.au=Pham%2C+Nhu-An&rft.au=Tong%2C+Jiefei&rft.au=Sakashita%2C+Shingo&rft.date=2017-02-01&rft.eissn=1097-0215&rft.volume=140&rft.issue=3&rft.spage=662&rft_id=info:doi/10.1002%2Fijc.30472&rft_id=info%3Apmid%2F27750381&rft.externalDocID=27750381
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0020-7136&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0020-7136&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0020-7136&client=summon